tiprankstipranks
Medlive Technology Co., Ltd. (HK:2192)
:2192
Hong Kong Market
2192
Medlive Technology Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:2192 full AI Analyst Report?

Medlive Technology Co., Ltd. (2192) Ratios

1 Followers

Medlive Technology Co., Ltd. Ratios

HK:2192's free cash flow for Q4 2025 was ¥0.59. For the 2025 fiscal year, HK:2192's free cash flow was decreased by ¥ and operating cash flow was ¥0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 19.09 19.09 21.03 24.10 32.78
Quick Ratio
 19.09 19.09 21.03 24.09 32.78
Cash Ratio
 12.28 12.28 18.56 22.97 31.54
Solvency Ratio
 1.51 1.51 1.26 1.01 0.74
Operating Cash Flow Ratio
 0.74 0.64 0.52 0.54 0.58
Short-Term Operating Cash Flow Coverage
 19.48 17.01 0.00 0.00 0.00
Net Current Asset Value
¥ 3.76B¥ 3.76B¥ 4.10B¥ 4.32B¥ 4.18B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.06 1.06 1.06 1.06 1.05
Debt Service Coverage Ratio
 20.40 20.50 141.45 724.35 256.01
Interest Coverage Ratio
 589.23 306.33 68.25 54.91 28.56
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.01 0.01 0.03 0.01 0.02
Net Debt to EBITDA
 -14.37 -13.81 -31.50 -16.55 -28.89
Profitability Margins
Gross Profit Margin
58.77%57.58%58.59%61.00%67.74%
EBIT Margin
25.49%26.33%21.03%61.53%43.17%
EBITDA Margin
27.96%29.62%21.73%63.80%46.03%
Operating Profit Margin
19.75%26.33%9.61%4.81%4.83%
Pretax Profit Margin
56.08%56.11%60.97%61.44%43.00%
Net Profit Margin
52.05%52.07%56.43%58.81%37.36%
Continuous Operations Profit Margin
54.15%54.18%59.15%61.11%40.25%
Net Income Per EBT
92.80%92.80%92.56%95.72%86.88%
EBT Per EBIT
283.99%213.07%634.66%1277.09%890.28%
Return on Assets (ROA)
6.42%6.31%6.17%4.95%2.55%
Return on Equity (ROE)
6.83%6.69%6.57%5.27%2.67%
Return on Capital Employed (ROCE)
2.54%3.33%1.09%0.42%0.34%
Return on Invested Capital (ROIC)
2.45%3.21%1.06%0.42%0.32%
Return on Tangible Assets
6.76%6.65%6.51%5.18%2.63%
Earnings Yield
6.00%5.10%4.59%4.56%2.18%
Efficiency Ratios
Receivables Turnover
 2.51 2.47 3.08 2.64 2.53
Payables Turnover
 11.78 11.90 16.68 10.88 37.40
Inventory Turnover
 0.00 0.00 0.00 1.62K 509.11
Fixed Asset Turnover
 19.35 19.01 14.68 37.20 21.55
Asset Turnover
 0.12 0.12 0.11 0.08 0.07
Working Capital Turnover Ratio
 0.17 0.16 0.13 0.10 0.08
Cash Conversion Cycle
 114.41 117.33 96.65 104.80 135.32
Days of Sales Outstanding
 145.41 147.99 118.53 138.13 144.36
Days of Inventory Outstanding
 0.00 0.00 0.00 0.22 0.72
Days of Payables Outstanding
 31.00 30.66 21.88 33.56 9.76
Operating Cycle
 145.41 147.99 118.53 138.36 145.08
Cash Flow Ratios
Operating Cash Flow Per Share
 0.21 0.18 0.15 0.14 0.11
Free Cash Flow Per Share
 0.19 0.17 0.12 0.09 0.10
CapEx Per Share
 0.02 0.02 0.03 0.04 0.01
Free Cash Flow to Operating Cash Flow
 0.92 0.90 0.81 0.68 0.90
Dividend Paid and CapEx Coverage Ratio
 0.78 0.68 0.54 0.65 3.93
Capital Expenditure Coverage Ratio
 13.24 10.48 5.19 3.13 10.31
Operating Cash Flow Coverage Ratio
 15.24 13.30 4.79 12.43 6.85
Operating Cash Flow to Sales Ratio
 0.24 0.22 0.19 0.25 0.25
Free Cash Flow Yield
2.56%1.91%1.27%1.30%1.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.65 19.61 21.77 21.95 45.86
Price-to-Sales (P/S) Ratio
 8.75 10.21 12.28 12.91 17.13
Price-to-Book (P/B) Ratio
 1.13 1.31 1.43 1.16 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
 39.09 52.49 78.46 76.69 77.20
Price-to-Operating Cash Flow Ratio
 35.82 47.48 63.34 52.20 69.71
Price-to-Earnings Growth (PEG) Ratio
 3.58 8.43 0.72 0.21 0.32
Price-to-Fair Value
 1.13 1.31 1.43 1.16 1.22
Enterprise Value Multiple
 16.91 20.67 25.04 3.68 8.34
Enterprise Value
 3.01B 3.83B 3.04B 967.29M 1.20B
EV to EBITDA
 16.91 20.67 25.04 3.68 8.34
EV to Sales
 4.73 6.12 5.44 2.35 3.84
EV to Free Cash Flow
 21.14 31.47 34.75 13.95 17.29
EV to Operating Cash Flow
 19.54 28.47 28.05 9.50 15.61
Tangible Book Value Per Share
 6.37 6.37 6.23 6.02 6.01
Shareholders’ Equity Per Share
 6.63 6.64 6.52 6.26 6.16
Tax and Other Ratios
Effective Tax Rate
 0.03 0.03 0.03 <0.01 0.06
Revenue Per Share
 0.87 0.85 0.76 0.56 0.44
Net Income Per Share
 0.45 0.44 0.43 0.33 0.16
Tax Burden
 0.93 0.93 0.93 0.96 0.87
Interest Burden
 2.20 2.13 2.90 1.00 1.00
Research & Development to Revenue
 0.12 0.12 0.12 0.00 0.15
SG&A to Revenue
 0.27 0.19 0.37 0.35 0.39
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.01 0.03 0.05
Income Quality
 0.46 0.37 0.32 0.40 0.57
Currency in CNY